Marie joined Antineo in June 2022 as Study Director and Head of Business Development.
She is in charge of establishing the study designs with the clients, of transmitting the client’s requests and needs to the operational team, and redacting the Study Reports.
Marie obtained her PhD in Pharmacology at the University of Lille, for her work on characterizing and evaluating the efficacy of small anti-Alzheimer molecules in mouse models. During her PhD, she acquired a solid experience in experimentation on rodents and small molecules, and she validated her Level I for Animal Experimentation.